Are the Cutaneous Manifestations During or Due to SARS-CoV-2 Infection/COVID-19 Frequent or Not? Revision of Possible Pathophysiologic Mechanisms
June 2020
in “
Inflammation Research
”
cutaneous manifestations SARS-CoV-2 COVID-19 innate immune response hypercoagulability cytokine storms chilblain urticarial eruptions erythema ACE2 receptor TMPRSS2 protease androgens thrombophilia coagulopathy skin manifestations immune response blood clotting skin lesions ACE2 TMPRSS2 male hormones blood clotting disorders
Studysummary This review discusses the complex pathophysiological and clinical aspects of COVID-19, including dermatological findings and their association with SARS-CoV-2 infection but reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →